FDA Dietary Supplement AER Detection, Analysis Need Refining – ASCPT
This article was originally published in The Tan Sheet
Executive Summary
The American Society for Clinical Pharmacology & Therapeutics is calling for legislation and funding that would enable FDA to improve the detection and assessment of adverse events associated with dietary supplement use